Abstract:Objective To examine the kinetics of plasma S100A12 and soluble receptor for advanced glycation end products (sRAGE) in infants and young children undergoing cardiopulmonary bypass ( CPB),and to investigate whether they could protective the occurrence of noninfectious pulmonary complication (NPC) after cardiac surgery.Methods This was a case-control study.The subjects included all children aged ＜3 years old who underwent cardiac surgery with CPB during the period from June 1st to July 31st 2011.The patient who showed pulmonary inflammation or had abnormal liver or renal function before surgery was excluded.The remain patients were divided into 2 groups according to whether they had developed NPC postoperatively.Twenty patients were grouped into NPC because they developed the complications of pleural effusion,chylothorax,partial lung collapse,pulmonary hypertensive crisis,airway disorders,pneumothorax,pneumomediastinum,or phrenic nerve palsy.Forty patients were categorized into the no-NPC group.Plasma concentrations of S100A12 and sRAGE were measured using ELISA at baseline,before CPB,immediately after CPB,1 h,12 h and 24 h after operation.Differences concentrations between two groups were analyzed with t test.A stepwise logistic regression analysis was used to indentify the independent risk factor for NPC.A P value ＜0.05 was considered statistically significant.Results Plasma levels of S100A12 and sRAGE dramatically increased immediately after CPB ( P ＜ 0.01 ).The levels of sRAGE dropped to lower than baseline level (P ＜0.05),while S100A12 was still at high level 24h after operation (P ＜0.01 ).Levels of S100A12 and sRAGE immediately after CPB in NPC group were significantly higher than the no-NPC group (P ＜ 0.05).Twenty-four hours after operation,levels of S100A12 were still higher in NPC group than no-NPC (P ＜ 0.01 ),while levels of sRAGE were similar in the two groups ( P ＞ 0.05 ).In the stepwise logistic regression analysis,plasma S100A12 level immediately after CPB remained as a independently predictor for postoperative NPC (OR =1.042,95％ CI:1.010 ～ 1.076,P =0.011 ).Levels of S100A12 immediately after CPB were positively associated with mechanical ventilation time ( r =0.47,P ＜ 0.01 ),duration of surgical Intensive Care Unit ( r =0.407,P =0.002) and hospital stay ( r =0.421,P =0.01 ).Conclusions Plasma levels of S100A12 and sRAGE were significantly increased immediately after CPB and the elevated plasma S100A12 immediately after CPB served as an early reliable biomarker of the occurrence and the prognosis of NPC after CPB in infants and young children.

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

Variations and Significance of IL-8 in the Bronchoalveolar Lavage Fluid in the Perioperative Period of Cardiopulmonary Bypass Operation on Children

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

Changes in Phospholipase D Activity of Leukocytes During Human Systemic Inflammatory Response Syndrome Induced by Cardiopulmonary Bypass.

Heparin-binding Protein As a Biomarker of Severe Sepsis in the Pediatric Intensive Care Unit: A Multicenter, Prospective Study

Adhesion Molecules and Cardiopulmonary Bypass -Induced Lung Injury

Effects of Pulmonary Protective Solution Involved Ulinastatin on Lung Function after Cardioopulmonary Bypass

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Clinical significance of pulse indicator continuous cardiac output in pediatric patients undergoing open-heart surgery

The Role of Plasma Gelsolin in Cardiopulmonary Bypass Induced Acute Lung Injury in Infants and Young Children: a Pilot Study

Effects of Combination of Ultrafiltration of Routine and Improved Method on the Expression of Cytokines and Cell Adhesion Molecules in Perioperative Period of Cardiopulmonary Bypass in Children

Levels of Plasma Endothelin-1, Circulating Endothelial Cells, Endothelial Progenitor Cells, and Cytokines after Cardiopulmonary Bypass in Children with Congenital Heart Disease: Role of Endothelin-1 Regulation

Expression of Adhesion Molecule of Myocardial Tissue During Cardiopulmonary Bypass and Influence of Aprotinin

Promising results of a clinical feasibility study: CIRBP as a potential biomarker in pediatric cardiac surgery

Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

Plasma Gelsolin Level Predicts Acute Kidney Injury after Cardiopulmonary Bypass in Infants and Young Children

Serum level of calpains product as a novel biomarker of acute lung injury following cardiopulmonary bypass

Changes of Plasma Soluble Fas and Soluble Fas Ligand in Patients Undergoing Coronary Artery Bypass Surgery with or Without Cardiopulmonary Bypass

Clinical Significance of the Serum-Soluble Intercellular Adhesion Molecule-1 in Patients Undergoing Radical Resection of Lung Cancer